Replikins, LLC and Replikins, Ltd., privately held limited liability companies were formed in 2006 to develop vaccines and disease surveillance software for pandemic preparedness and response. The US headquarters of the Companies is in Boston, Massachusetts. The Replikins Companies have made substantial breakthroughs in prediction and disease surveillance based on quantitative computer driven analysis of replication in the genome that make such preparedness and rapid response with synthetic vaccines now possible. The company is developing vaccines for the animal and human markets.